Počet záznamov: 1
rivaroxaban
SYS d000069552 LBL 00000nx^^^2200181-^^45^^ 005 20240119195248.1 100 $a 20160101asloy0103 ba0 152 $b mesh 250 $a rivaroxaban $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 2016 (2005) $8 eng 330 1-
$a A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. $8 eng 450 $a BAY 59-7939 $5 e $8 slo 686 $a D02.886.778.727 686 $a D03.383.533.640.713 686 $a D03.383.903.727 750 $a Rivaroxaban $8 eng 801 -0
$a SK $b BA006 $c 20160207 801 -2
$a SK $b BA006 $c 20160215 980 $x M
Počet záznamov: 1